Allogeneic ABCB5-positive Stem Cells for Treatment of CVU
Clinical trial NCT03257098 · COMPLETED
Trial details
- NCT number
- NCT03257098
- Sponsor
- RHEACELL GmbH & Co. KG
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-16
- Primary completion
- 2020-06-25
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.